Advances in adult asthma diagnosis and treatment and health outcomes, education, delivery, and quality in 2008

Journal of Allergy and Clinical Immunology

Volumn 123, Issue 1, 2009, Pages 35-40

  Apter, Andrea J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

adults; Asthma; chlorofluorocarbon; exhaled breath condensate; genetics; health literacy; inhaled corticosteroids; nitric oxide; short acting agonists

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BIOLOGICAL MARKER; CHLOROFLUOROCARBON; CLOPIDOGREL; CORTICOSTEROID; DEXAMETHASONE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MALONALDEHYDE; METHACHOLINE; MONTELUKAST; NITRIC OXIDE; OMALIZUMAB; PLACEBO; PNEUMOCOCCUS VACCINE; SALBUTAMOL;

ARTICLE; ASTHMA; BRONCHOSPASM; CARDIOVASCULAR DISEASE; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG COST; DRUG EFFICACY; EMERGENCY WARD; ENVIRONMENTAL EXPOSURE; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH EDUCATION; HUMAN; INTERPERSONAL COMMUNICATION; LOW DRUG DOSE; MINORITY GROUP; MORBIDITY; OBESITY; OZONE DEPLETION; PH; PNEUMOCOCCAL INFECTION; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK FACTOR; SKIN TEST; SMOKING CESSATION; UNSPECIFIED SIDE EFFECT; URBAN AREA;

ADULT; ASTHMA; EMERGENCY MEDICAL SERVICES; FEMALE; HUMANS; MALE; PATIENT EDUCATION AS TOPIC; PNEUMOCOCCAL INFECTIONS; QUALITY ASSURANCE, HEALTH CARE; RISK FACTORS; TOBACCO SMOKE POLLUTION;

EID: 58149184028     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.11.017     Document Type: Article

References (84)

1. Apter A.J. Clinical advances in adult asthma. J Allergy Clin Immunol 111 (2003) S780-S784
2. Apter A.J. Advances in adult asthma 2006: its risk factors, course, and management. J Allergy Clin Immunol 119 (2007) 563-566
3. Apter A.J. Advances in the care of adults with asthma and allergy in 2007. J Allergy Clin Immunol 121 (2008) 839-844
4. Apter A.J., and Szefler S.J. Advances in adult and pediatric asthma. J Allergy Clin Immunol 113 (2004) 407-414
5. Apter A.J., and Szefler S.J. Advances in adult and pediatric asthma. J Allergy Clin Immunol 117 (2006) 512-518
6. Szefler S.J., and Apter A. Advances in pediatric and adult asthma. J Allergy Clin Immunol 115 (2005) 470-477
7. Pedersen S., and O'Byrne P.M. Exhaled nitric oxide in guideline-based asthma management. Lancet 372 (2008) 1015-1017
8. Hunt J.F., Fang K., Malik R., Snyder A., Malhotra N., Platts-Mills T.A., et al. Endogenous airway acidification: implications for asthma pathophysiology. Am J Respir Crit Care Med 161 (2000) 694-699
9. Hauswirth D.W., Sundy J.S., Mervin-Blake S., Fernandez C.A., Patch K.B., Alexander K.M., et al. Normative values for exhaled breath condensate pH and its relationship to exhaled nitric oxide in healthy African Americans. J Allergy Clin Immunol 122 (2008) 101-106
10. Gaston B., Kelly R., Urban P., Liu L., Henderson E.M., Doctor A., et al. Buffering airway acid decreases exhaled nitric oxide in asthma. J Allergy Clin Immunol 118 (2006) 817-822
11. Shin H.W., Shelley D.A., Henderson E.M., Fitzpatrick A., Gaston B., and George S.C. Airway nitric oxide release is reduced after PBS inhalation in asthma. J Appl Physiol 102 (2007) 1028-1033
12. Craig T.J., King T.S., Lemanske Jr. R.F., Wechsler M.E., Icitovic N., Zimmerman Jr. R.R., et al. Aeroallergen sensitization correlates with PC(20) and exhaled nitric oxide in subjects with mild-to-moderate asthma. J Allergy Clin Immunol 121 (2008) 671-677
13. Szefler S.J., Mitchell H., Sorkness C.A., Gergen P.J., O'Connor G.T., Morgan W.J., et al. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet 372 (2008) 1065-1072
14. Expert Panel Report 3: guidelines for the diagnosis and management of asthma, full report 2007 (2007), US Department of Health and Human Services, National Institutes of Health, National Heart, Lung and Blood Institute, Bethesda (MD)
15. Levesque M.C., Hauswirth D.W., Mervin-Blake S., Fernandez C.A., Patch K.B., Alexander K.M., et al. Determinants of exhaled nitric oxide levels in healthy, nonsmoking African American adults. J Allergy Clin Immunol 121 (2008) 396-402 e3
16. Park S.S., and Grayson M.H. Clinical research: protection of the "vulnerable". J Allergy Clin Immunol 121 (2008) 1103-1107
17. Romieu I., Barraza-Villarreal A., Escamilla-Nunez C., Almstrand A.C., Diaz-Sanchez D., Sly P.D., et al. Exhaled breath malondialdehyde as a marker of effect of exposure to air pollution in children with asthma. J Allergy Clin Immunol 121 (2008) 903-909 e6
18. Van Eerdewegh P., Little R.D., Dupuis J., Del Mastro R.G., Falls K., Simon J., et al. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 418 (2002) 426-430
19. Tantisira K.G., Silverman E.S., Mariani T.J., Xu J., Richter B.G., Klanderman B.J., et al. FCER2: a pharmacogenetic basis for severe exacerbations in children with asthma. J Allergy Clin Immunol 120 (2007) 1285-1291
20. Tantisira K.G., Lazarus R., Litonjua A.A., Klanderman B., and Weiss S.T. Chromosome 17: association of a large inversion polymorphism with corticosteroid response in asthma. Pharmacogenet Genomics 18 (2008) 733-737
21. Litonjua A.A., Lasky-Su J., Schneiter K., Tantisira K.G., Lazarus R., Klanderman B., et al. ARG1 is a novel bronchodilator response gene: screening and replication in four asthma cohorts. Am J Respir Crit Care Med 178 (2008) 688-694
22. Raby B.A., Silverman E.K., Kwiatkowski D.J., Lange C., Lazarus R., and Weiss S.T. ADAM33 polymorphisms and phenotype associations in childhood asthma. J Allergy Clin Immunol 113 (2004) 1071-1078
23. Dijkstra A., Koppelman G.H., Vonk J.M., Bruinenberg M., Schouten J.P., and Postma D.S. Pharmacogenomics and outcome of asthma: no clinical application for long-term steroid effects by CRHR1 polymorphisms. J Allergy Clin Immunol 121 (2008) 1510-1513
24. Tavendale R., Macgregor D.F., Mukhopadhyay S., and Palmer C.N. A polymorphism controlling ORMDL3 expression is associated with asthma that is poorly controlled by current medications. J Allergy Clin Immunol 121 (2008) 860-863
25. Hendeles L., Colice G.L., and Meyer R.J. Withdrawal of albuterol inhalers containing chlorofluorocarbon propellants. N Engl J Med 356 (2007) 1344-1351
26. Evolution of the Montreal Protocol. United Nations Environmental Programme, 2007. Available at: http://ozone.unep.org/Ratification_Status/evolution_of_mp.html. Accessed December 9, 2008.
27. Leo H.L., Dombkowski K.J., and Clark N.M. The economic effect of the hydrofluoroalkane albuterol transition on children with asthma. J Allergy Clin Immunol 121 (2008) 776-777
28. National Assessment of Adult Literacy (2003), National Center for Education Statistics, Institute of Education Sciences, US Department of Education, Washington (DC)
29. Smith H., Wade J., and Frew A. How readable are the American Academy of Allergy, Asthma & Immunology "Tips to Remember" leaflets?. J Allergy Clin Immunol 121 (2008) 770-773
30. In: Nielson-Bohlman L., Panzer A., and Kindig D. (Eds). Health literacy: a prescription to end confusion (2004), National Academies Press, Washington (DC)
31. Parikh N.S., Parker R.M., Nurss J.R., Baker D.W., and Williams M.V. Shame and health literacy: the unspoken connection. Patient Educ Couns 27 (1996) 33-39
32. Weiss B.D., and Coyne C. Communicating with patients who cannot read. N Engl J Med 337 (1997) 272-274
33. Unequal treatment: confronting racial and ethnic disparities in health care (2003), Institute of Medicine, National Academies Press, Washington (DC)
34. Apter A.J., Cheng J., Small D., Bennett I.M., Albert C., Fein D., et al. Asthma numeracy skill and health literacy. J Asthma 43 (2006) 705-710
35. Paasche-Orlow M.K., Riekert K.A., Bilderback A., Chanmugam A., Hill P., Rand C.S., et al. Tailored education may reduce health literacy disparities in asthma self-management. Am J Respir Crit Care Med 172 (2005) 980-986
36. Williams M.V., Baker D.W., Honig E.G., Lee T.M., and Nowlan A. Inadequate literacy is a barrier to asthma knowledge and self-care. Chest 114 (1998) 1008-1015
37. Apter A.J., Paasche-Orlow M.K., Remillard J.T., Bennett I.M., Ben-Joseph E.P., Batista R.M., et al. Numeracy and communication with patients: they are counting on us. J Gen Intern Med (2008) Oct 2 [epub ahead of print]
38. Juniper E.F., Guyatt G.H., Cox F.M., Ferrie P.J., and King D.R. Development and validation of the Mini Asthma Quality of Life Questionnaire. Eur Respir J 14 (1999) 32-38
39. Nathan R.A., Sorkness C.A., Kosinski M., Schatz M., Li J.T., Marcus P., et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 113 (2004) 59-65
40. Vollmer W.M., Markson L.E., O'Connor E., Frazier E.A., Berger M., and Buist A.S. Association of asthma control with health care utilization: a prospective evaluation. Am J Respir Crit Care Med 165 (2002) 195-199
41. Skinner E.A., Diette G.B., Algatt-Bergstrom P.J., Nguyen T.T., Clark R.D., Markson L.E., et al. The Asthma Therapy Assessment Questionnaire (ATAQ) for children and adolescents. Dis Manag 7 (2004) 305-313
42. Patino C.M., Okelo S.O., Rand C.S., Riekert K.A., Krishnan J.A., Thompson K., et al. The Asthma Control and Communication Instrument: a clinical tool developed for ethnically diverse populations. J Allergy Clin Immunol 122 (2008) 936-943
43. Juniper E.F., Schatz M., Juniper B.A., and Zeiger R.S. Evaluation of 2 interactive voice-response telephone versions of health-related quality-of-life questionnaires. J Allergy Clin Immunol 122 (2008) 654-655
44. Juniper E.F., Buist A.S., Cox F.M., Ferrie P.J., and King D.R. Validation of a standardized version of the Asthma Quality of Life Questionnaire. Chest 115 (1999) 1265-1270
45. Juniper E.F., Thompson A.K., Ferrie P.J., and Roberts J.N. Development and validation of the mini Rhinoconjunctivitis Quality of Life Questionnaire. Clin Exp Allergy 30 (2000) 132-140
46. Marsden P.A., Smith J.A., Kelsall A.A., Owen E., Naylor J.R., Webster D., et al. A comparison of objective and subjective measures of cough in asthma. J Allergy Clin Immunol 122 (2008) 903-907
47. Blais L., and Forget A. Asthma exacerbations during the first trimester of pregnancy and the risk of congenital malformations among asthmatic women. J Allergy Clin Immunol 121 (2008) 1379-1384 e1
48. Mosen D.M., Schatz M., Magid D.J., and Camargo Jr. C.A. The relationship between obesity and asthma severity and control in adults. J Allergy Clin Immunol 122 (2008) 507-511 e6
49. Litonjua A.A., and Gold D.R. Asthma and obesity: common early-life influences in the inception of disease. J Allergy Clin Immunol 121 (2008) 1075-1084 quiz 85-6
50. Shore S.A. Obesity and asthma: possible mechanisms. J Allergy Clin Immunol 121 (2008) 1087-1093 quiz 94-5
51. Mehra R., and Redline S. Sleep apnea: a proinflammatory disorder that coaggregates with obesity. J Allergy Clin Immunol 121 (2008) 1096-1102
52. Moorman J.E., Rudd R.A., Johnson C.A., King M., Minor P., Bailey C., et al. National surveillance for asthma-United States, 1980-2004. MMWR Surveill Summ 56 (2007) 1-54
53. Ginde A.A., Espinola J.A., and Camargo Jr. C.A. Improved overall trends but persistent racial disparities in emergency department visits for acute asthma, 1993-2005. J Allergy Clin Immunol 122 (2008) 313-318
54. Miller T.P., Oswald F.L., and Reeves M.J. An exploration of factors underlying asthma care and morbidity: a factor analysis of clinical variables. J Allergy Clin Immunol 122 (2008) 328-334 e1-5
55. Riekert K.A., and Eakin M. Factor analysis: a primer for asthma researchers. J Allergy Clin Immunol 121 (2008) 1181-1183
56. O'Connor G.T., Neas L., Vaughn B., Kattan M., Mitchell H., Crain E.F., et al. Acute respiratory health effects of air pollution on children with asthma in US inner cities. J Allergy Clin Immunol 121 (2008) 1133-1139 e1
57. Rand C.S., and Apter A.J. Mind the widening gap: have improvements in asthma care increased asthma disparities?. J Allergy Clin Immunol 122 (2008) 319-321
58. Taylor D.R., and Hannah D. Management of beta-agonist overuse: why and how?. J Allergy Clin Immunol 122 (2008) 836-838
59. Cooper P.R., and Panettieri Jr. R.A. Steroids completely reverse albuterol-induced beta(2)-adrenergic receptor tolerance in human small airways. J Allergy Clin Immunol 122 (2008) 734-740
60. Zeiger R.S., Hay J.W., Contreras R., Chen W., Quinn V.P., Seal B., et al. Asthma costs and utilization in a managed care organization. J Allergy Clin Immunol 121 (2008) 885-892 e5
61. Boushey H.A., Sorkness C.A., King T.S., Sullivan S.D., Fahy J.V., Lazarus S.C., et al. Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med 352 (2005) 1519-1528
62. Busse W.W., Shah S.R., Somerville L., Parasuraman B., Martin P., and Goldman M. Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients. J Allergy Clin Immunol 121 (2008) 1407-1414 e1-6
63. Juhn Y.J., Kita H., Yawn B.P., Boyce T.G., Yoo K.H., McGree M.E., et al. Increased risk of serious pneumococcal disease in patients with asthma. J Allergy Clin Immunol 122 (2008) 719-723
64. Talbot T.R., Hartert T.V., Mitchel E., Halasa N.B., Arbogast P.G., Poehling K.A., et al. Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med 352 (2005) 2082-2090
65. Hartert T.V. Are persons with asthma at increased risk of pneumococcal infections, and can we prevent them?. J Allergy Clin Immunol 122 (2008) 724-725
66. Barr R.G., Kurth T., Stampfer M.J., Buring J.E., Hennekens C.H., and Gaziano J.M. Aspirin and decreased adult-onset asthma: randomized comparisons from the Physicians' Health Study. Am J Respir Crit Care Med 175 (2007) 120-125
67. Barr R.G., Wentowski C.C., Curhan G.C., Somers S.C., Stampfer M.J., Schwartz J., et al. Prospective study of acetaminophen use and newly diagnosed asthma among women. Am J Respir Crit Care Med 169 (2004) 836-841
68. Menzies D., Nair A., Meldrum K.T., Hopkinson P., and Lipworth B.J. Effect of aspirin on airway inflammation and pulmonary function in patients with persistent asthma. J Allergy Clin Immunol 121 (2008) 1184-1189 e4
69. Shaker M., Lobb A., Jenkins P., O'Rourke D., Takemoto S.K., Sheth S., et al. An economic analysis of aspirin desensitization in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 121 (2008) 81-87
70. The new drug development process. In: Center for Drug Evaluation and Research USFaDA, ed. Rockville (MD): 2008. Available at: http://www.fda.gov/CDER/HANDBOOK/DEVELOP.htm. Accessed December 5, 2008.
71. Early communication about an ongoing safety review of montelukast (Singulair) (2008), Center for Drug Evaluation and Research, US Food and Drug Administration, Rockville (MD)
72. Holbrook J.T., and Harik-Khan R. Montelukast and emotional well-being as a marker for depression: Results from 3 randomized, double-masked clinical trials. J Allergy Clin Immunol 122 (2008) 828-829
73. Juniper E.F., Guyatt G.H., Feeny D.H., Ferrie P.J., Griffith L.E., and Townsend M. Measuring quality of life in children with asthma. Qual Life Res 5 (1996) 35-46
74. Radloff L.S. The CES-D Scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1 (1977) 385-401
75. Ware Jr. J.E., and Sherbourne C.D. The MOS 36-item short-form health survey (SF-36), I: conceptual framework and item selection. Med Care 30 (1992) 473-483
76. Limb S.L., Starke P.R., Lee C.E., and Chowdhury B.A. Delayed onset and protracted progression of anaphylaxis after omalizumab administration in patients with asthma. J Allergy Clin Immunol 120 (2007) 1378-1381
77. Barry P.J., O'Mahony A., Finnegan C., and O'Connor T.M. Delayed allergic reactions to omalizumab: are patients reporting all cases?. J Allergy Clin Immunol 121 (2008) 785-786 author reply 6
78. Limb S.L., Lee C.E., Starke P.R., and Chowdhury B.A. Reply. J Allergy Clin Immunol 121 (2008) 786
79. Cresswell K.M., and Sheikh A. Information technology-based approaches to reducing repeat drug exposure in patients with known drug allergies. J Allergy Clin Immunol 121 (2008) 1112-1117 e7
80. Rayens M.K., Burkhart P.V., Zhang M., Lee S., Moser D.K., Mannino D., et al. Reduction in asthma-related emergency department visits after implementation of a smoke-free law. J Allergy Clin Immunol 122 (2008) 537-541 e3
81. Rabinovitch N. Smoky, and they banned it!. J Allergy Clin Immunol 122 (2008) 542-543
82. Kumar R., Curtis L.M., Khiani S., Moy J., Shalowitz M., Sharp L., et al. A community-based study of tobacco smoke exposure among inner-city children with asthma in Chicago. J Allergy Clin Immunol 122 (2008) 754-759
83. Salo P.M., Arbes Jr. S.J., Crockett P.W., Thorne P.S., Cohn R.D., and Zeldin D.C. Exposure to multiple indoor allergens in US homes and its relationship to asthma. J Allergy Clin Immunol 121 (2008) 678-684 e2
84. Hunninghake G.M., Soto-Quiros M.E., Lasky-Su J., Avila L., Ly N.P., Liang C., et al. Dust mite exposure modifies the effect of functional IL10 polymorphisms on allergy and asthma exacerbations. J Allergy Clin Immunol 122 (2008) 93-98 e1-5